EUVIMEDEUVIMED entdecken
Crossref

Favorable outcomes in Hispanic recipients receiving simultaneous pancreas kidney transplantation

Pooja Budhiraja iD, Kunam S Reddy iD, Raymond L Heilman iD, Caroline C Jadlowiec iD, Hassan Khamash iD, Swetha Reddy iD, Nitin Katariya, Harini A Chakkera iD

Clinical Transplantation · 2023

DOI: 10.1111/ctr.15062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation, 2023. Verfasst von Pooja Budhiraja und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medicine, Mayo Clinic Arizona, Phoenix, Arizona, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Kidney Transplantation, Pancreas Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The objective of this study was to compare the long‐term outcomes of Hispanic versus white recipients who underwent simultaneous pancreas kidney transplantation (SPKT). This single‐center study, conducted from 2003 to 2022, had a median follow‐up of 7.5 years. The study included 91 Hispanic and 202 white SPKT recipients. The mean age (44 vs. 46 years), percentage of males (67% vs. 58%), and body mass index (BMI) (25.6 vs. 25.3 kg/m 2 ) were similar between the Hispanic and white groups. The Hispanic group had more recipients with type 2 diabetes (38%) compared to the white group (5%, p < .001). The duration of dialysis was longer in Hispanics (640 vs. 473 days, p = .02), and fewer patients received preemptive transplants (10% vs. 29%, p < .01) compared to whites. Hospital length of stay, rates of BK Viremia, and acute rejection episodes within 1 year were similar between the groups. The estimated 5‐year kidney, pancreas, and patient survival rates were also similar between the groups, 94%, 81%, and 95% in Hispanics, compared to 90%, 79%, and 90% in whites. Increasing age and longer duration of dialysis were risk factors for death. Although Hispanic recipients had a longer duration on dialysis and fewer preemptive transplants, the survival rates were similar to those of white recipients. However, referring providers and many transplant centers continue to overlook pancreas transplants for appropriately selected patients with type 2 diabetes, particularly among minority populations. As a transplant community, it is crucial that we make efforts to comprehend and tackle these obstacles to transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Kidney TransplantationPancreas TransplantationHumansMaleGraft SurvivalHispanic or LatinoPancreasFemaleAdultMiddle Aged

Stichwörter der Autor:innen

Hispanicgraft survivalracesimultaneous pancreas-kidney transplantationwhites

Autor:innen und Institutionen

  • Division of Medicine, Mayo Clinic Arizona, Phoenix, Arizona, USA.
  • Department of Surgery, Mayo Clinic Arizona, Phoenix, Arizona, USA.
  • Department of Medicine, Mayo Clinic Rochester, Rochester, Minnesota, USA.

ORCID-Profile: Pooja Budhiraja, Kunam S Reddy, Raymond L Heilman, Caroline C Jadlowiec, Hassan Khamash, Swetha Reddy, Harini A Chakkera

Zitieren

APA

Budhiraja, P., Reddy, K. S., Heilman, R. L., Jadlowiec, C. C., Khamash, H., Reddy, S., Katariya, N., & Chakkera, H. A. (2023). Favorable outcomes in Hispanic recipients receiving simultaneous pancreas kidney transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.15062

Vancouver

Budhiraja P, Reddy KS, Heilman RL, Jadlowiec CC, Khamash H, Reddy S, et al. Favorable outcomes in Hispanic recipients receiving simultaneous pancreas kidney transplantation. Clinical Transplantation. 2023. doi:10.1111/ctr.15062

BibTeX
@article{Budhiraja2023,
  author = {Budhiraja, Pooja and Reddy, Kunam S and Heilman, Raymond L and Jadlowiec, Caroline C and Khamash, Hassan and Reddy, Swetha and Katariya, Nitin and Chakkera, Harini A},
  title = {Favorable outcomes in Hispanic recipients receiving simultaneous pancreas kidney transplantation},
  journal = {Clinical Transplantation},
  year = {2023},
  doi = {10.1111/ctr.15062}
}
Kostenlos starten →